Page 45 - IPO Tracker

boAt's parent firm Imagine Marketing secures Sebi approval for IPO

Imagine Marketing, parent company of boAt, has secured Sebi approval for its IPO through the pre-filing route, eyeing a $1.5 bn valuation

IPO listing forecast: GMP hints at muted start for Anlon Healthcare shares

Anlon Healthcare shares garnered decent demand, being oversubscribed by 7.13 times

Amanta Healthcare IPO Day 2 update: Subscription rises 11x, GMP at 9%

Analysts at Anand Rathi Research recommended investors to subscribe to the Amanta Healthcare IPO from a long-term perspective

Vikran Engineering IPO to list on Sep 3: Here's what latest GMP hints at

Ahead of the listing, unlisted shares of Vikran Engineering were commanding a decent premium in unofficial market trades

Reliance Jio's IPO could be India's largest at ₹30,000 crore: Motilal Oswal

MOSL has thus valued Reliance Industries' stake in JPL at ₹7.91 trillion or $90 billion. JPL's enterprise value (EV; equity plus debt) has been pegged at $151 billion by the domestic brokerage

Kiaasa Retail gets BSE approval for ₹55 crore IPO to fund expansion plans

The Ghaziabad-based retailer had filed its draft red herring prospectus (DRHP) with the BSE on April 18 and secured final in-principle approval on August 29

Anlon Healthcare IPO booked 7x; check allotment status, GMP, listing date

Anlon Healthcare IPO was subscribed 7.13 times, receiving bids for 94.7 million shares against 13.3 million shares on offer

Current Infraprojects IPO booked 352x; check allotment status, latest GMP

Investors who applied for the Current Infraprojects IPO can check their allotment status online through the NSE or the registrar's website, Bigshare Services

Amanta Healthcare IPO opens today: GMP up 22%; should you apply or not?

Ahead of the opening, Amanta Healthcare raised ₹37.8 crore from six institutional investors through an anchor book on August 29

Binny Bansal-backed Winspark eyes IPO after two years of profitability

Winspark, parent of PlanetSpark, expects to be profitable in FY26 and plans an IPO after achieving two straight profitable years and ₹800 crore in revenue

Tata Capital to float $2 bn IPO in Sept last week, eyes $11 bn valuation

The issue is expected to value the company around $11 billion, they added. Tata Capital is likely to make its stock market debut by September 30

CMR Green Technologies files draft papers, seeks Sebi's nod to float IPO

The proposed IPO is entirely through an Offer for Sale (OFS) of 4.28 crore equity shares, according to the draft red herring prospectus (DRHP) filed on Friday

Vikran Engineering IPO sees 23.59 times subscription on last day

The initial public offer (IPO) is a mix of fresh issue of shares of about ₹721 crore and an offer-for-sale portion worth ₹51 crore by the promoter

Anlon Healthcare IPO booked 7.12 times offer size on closing day

The Rs 121-crore IPO received bids for 9,47,39,520 shares against 1,33,00,000 shares on offer, according to NSE data

Last day! Vikran Engineering IPO ends today; check latest subscription, GMP

Vikran Engineering IPO Day 3 update: Check latest subscription status, GMP, allotment date, listing date, reviews, and other key details here

Groww gets Sebi approval for $1 billion IPO at $7-8 billion valuation

Groww has received Sebi approval for its $1 billion IPO, which will be India's largest capital market fundraise, valuing the firm at $7-8 billion after profit tripled in FY25

Anlon Healthcare IPO subscribed 3.30 times on Day 2 of share sale

The initial public offer (IPO) has a fresh issue of aggregating up to 13.3 million shares

Current Infraprojects IPO Day 2 update: Subscription nears 24x, GMP up 56%

Current Infraprojects IPO: Check latest subscription status, GMP, allotment date, listing date, and other key details here

Amanta Healthcare IPO: Know key strengths, risks before you invest

Amanta Healthcare IPO is available at a price band of ₹120 to ₹126 per share, with a lot size of 119 shares

Retail investors rush for Anlon Healthcare IPO, NIIs follow; QIBs hold back

Non-institutional investors (NIIs) also showed steady interest, while qualified institutional buyers (QIBs) remained relatively subdued in their response